Open access · OA
via OpenAlex
Long‐Lasting Stabilization and Improvement of Dry Age‐Related Macular Degeneration by a High Oral Taurine Dose
Journal of Ophthalmology and Advance Research · 2023
Abstract
Purpose: To examine the therapeutic potential of the amino acid taurine in the non‐ neovascular or ∙dry” form of Age‐Related Macular Degeneration (AMD), one of the main causes of vision loss in the elderly, which still lacks effective treatments. Taurine is the most abundant amino acid in the retina and exerts trophic and neuroprotective actions in cellular and animal models. Likewise, a recent Science paper indicates that taurine deficiency is a driver of aging and that taurine supplementation may be an effective treatment for age‐related diseases. Case Description: A dry AMD patient (F.A., male, 62‐yr old) presented a Snellen best corrected visual acuity of 0.15 on the Right Eye (RE) and 0.2 on the Left Eye (LE) in June 2013, together with central retina atrophy and reduction of central macular thickness to 144 µm (RE) and 159 µn (LE) (OCT analysis; Topcon 3D OCT1000). Oral taurine intake (600 mg t.i.d.) arrested macular degeneration over a 5.5‐yr period and moderately improved visual acuity and macular thickness after doubling the dose from 1.8 g/day to 3.6 g/day in December 2018. This improvement remained stable until last control visit in January 2023. Conclusion: Taurine may have disease‐modifying properties in dry AMD at the dose used. The present observations add to existing literature to foster proof‐of‐concept clinical trials using a high oral dose of taurine for the treatment of AMD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.46889/joar.2023.4306
- Canonical
- link ↗
- Fetched
- 2026-11-01 MST
Cite this
APA
Artigas, F. (2023). Long‐Lasting Stabilization and Improvement of Dry Age‐Related Macular Degeneration by a High Oral Taurine Dose. <em>Journal of Ophthalmology and Advance Research</em>. https://doi.org/10.46889/joar.2023.4306
Vancouver
Artigas F. Long‐Lasting Stabilization and Improvement of Dry Age‐Related Macular Degeneration by a High Oral Taurine Dose. Journal of Ophthalmology and Advance Research. 2023. doi:10.46889/joar.2023.4306.
BibTeX
@article{francesc2023LongLa,
title = {Long‐Lasting Stabilization and Improvement of Dry Age‐Related Macular Degeneration by a High Oral Taurine Dose},
author = {Francesc Artigas},
journal = {Journal of Ophthalmology and Advance Research},
year = {2023},
doi = {10.46889/joar.2023.4306},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
CRC Press eBooks 2016
Citation only
Age-Related Macular Degeneration
International Ophthalmology 2010
Open access · CC-BY
Prevention of age-related macular degeneration
BENTHAM SCIENCE PUBLISHERS eBooks 2017
Citation only
Retinal Neurodegeneration in Alzheimer’s Disease
Current Medicinal Chemistry 2019
Citation only
Pharmacological Advances in the Treatment of Age-related Macular Degeneration
Biobizkaia Health Research Institute 2026
Open access · US-GOV
Efficacy of Faricimab in Patients With Subretinal Hyperreflective Material Associated With Type 2 or Mixed Neovascular Membranes Assessed by Multimodal Imaging
Medical Clinics of North America 2021
Open access · CC-BY